CT
HIMS icon

Clearstead Trust’s Hims & Hers Health HIMS Stock Holding History

Clearstead Trust’s Portfolio HIMS Stock Details HIMS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.25K Buy
+36
New +$966 ﹤0.01% 920

Other funds holding HIMS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
DSCM
Divisadero Street Capital Management Miami, Florida $4.41B AUM 90.53% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Clearstead Trust's HIMS Position: Q2 2026 in Review

Clearstead Trust opened a new position in Hims & Hers Health (HIMS) in Q2 2026: 36 shares worth $1.25K. The stake represents ﹤0.01% of the portfolio and ranks #920 among its holdings.

504 funds tracked by Wall St. Rank hold HIMS as of Q2 2026.

  • Clearstead Trust held 36 shares of Hims & Hers Health worth $1.25K as of Q2 2026.
  • Hims & Hers Health was a new Clearstead Trust position in Q2 2026.
  • Hims & Hers Health made up ﹤0.01% of Clearstead Trust's portfolio in Q2 2026, its #920 holding.
  • 504 funds tracked by Wall St. Rank held Hims & Hers Health as of Q2 2026.

Based on Clearstead Trust's 13F filing for Q2 2026, filed 6 Aug 2026.